Skip to main content
Clinical Trials/DRKS00032412
DRKS00032412
Not yet recruiting
Not Applicable

Evaluation of preoperative clinical and translational selection criteria for cytoreductive surgery in endometrial cancer - A retrospective multicenter trial with an accompanying translational project - STREAM-I

AGO Research GmbH0 sites800 target enrollmentAugust 11, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C54.1
Sponsor
AGO Research GmbH
Enrollment
800
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 11, 2023
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients \=18 years undergoing cytoreductive surgery for endometrial cancer between 01/2011 and 12/2020 with the following criteria:
  • \- Primary diagnosis of advanced endometrial cancer and peritoneal metastases (FIGO IV) undergoing cytoreductive surgery
  • \- Diagnosis of recurrent endometrial cancer undergoing cytoreductive surgery Optional but strongly encouraged for translational part:
  • availability of FFPE tumor material from cytoreductive surgery

Exclusion Criteria

  • 1\. Patients with past medical history interfering with radical cytoreductive surgery
  • 2\. Patients undergoing surgery solely for palliative intent
  • 3\. Patients with secondary

Outcomes

Primary Outcomes

Not specified

Similar Trials